The global bioprocessing analytics equipment market is on the threshold of transformative growth, with recent projections anticipating a revenue increase from USD 485.1 million in 2022 to USD 633.6 ...
We think Silgan has a sound capital structure, and we think its consistent free cash flow generation will support its debt-service requirements and future capital-allocation decisions. Silgan has ...